Nordwest Clinic (Krankenhaus)
Nordwest Clinic (Krankenhaus)
Germany, Frankfurt am Main
Elke Jaeger
41 years of experience
Clinic is certified :
Lung cancer stage 4 treatment cost in Germany generally includes essential diagnostics like a PET-CT scan and a chest CT, with a chest CT typically costing $400 to $600. Primary treatments such as pneumonectomy run from $45,000 to $65,000, while stereotaxic radiosurgery ranges from $25,000 to $35,000. Total expenses depend on the specific chemotherapy cycles and immunotherapy drugs used. Patients can find approximately 10-30% savings compared to the US in top medical hubs like Berlin, Hamburg, and Frankfurt.
Typical Lung Cancer Stage 4 Treatment Costs in Germany
Bookimed Expert Insight: Advanced stage patients requiring specialized immunotherapy protocols should consider centers with integrated research wings. Nordwest Clinic (Krankenhaus) is a leading choice. They develop anticancer vaccines under Prof. Elke Jaeger, a Focus-ranked specialist. For those prioritizing international patient services, Asklepios Hospital Barmbek is rated top by MTQUA. This clinic manages over 80,000 international cases annually with high satisfaction.
| Germany | Turkey | Austria | |
| Stereotaxic radiosurgery | from $25,000 | from $4,500 | from $17,000 |
| Radiation therapy for colorectal cancer | from $20,000 | from $7,000 | from $12,000 |
| Pneumonectomy | from $45,000 | from $10,872 | from $50,000 |
| Lung cancer surgery | from $19,583 | from $17,000 | from $42,000 |
| Chemotherapy for breast cancer | from $4,500 | from $1,200 | from $15,000 |
Prof. Elke Jaeger is one of Germany's top oncologists according to Focus rating, with _doctor_502_years_ of experience at Nordwest Clinic.
Professor Keil specializes in advanced imaging techniques for complex lung cancer cases, with leadership roles at top German radiology centers.
Specializes in molecular diagnostics and innovative therapies for advanced lung cancer at Medical Center in Solingen.
Head Physician at Bremen-Ost Clinic, treating over 500 lung cancer patients annually with a focus on immunotherapy.